Google News

By Anonymous User · February 24, 2026

Gilead Bets Big On New Drug With $7.8 Billion Deal As It Takes On J&J  Investor's Business DailyHere's Why Shares of Arcellx Are Up Almost 80% Today  Yahoo FinanceGilead to buy cancer therapy developer Arcellx for up to $7.8 billion  CNBCGilead Sciences to Buy Arcellx in Deal Valued at $7.8 Billion  WSJGilead inks $8B Arcellx buyout to steer CAR-T into J&J showdown  Fierce Biotech